BIO seeks dynamic, professional candidates with industry expertise and knowledge for our open positions. If you're interested in joining our team, please see the links below to view our current ...

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented ...

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies: "For too many years, ...

A Most Favored Nation (MFN) pricing agreement was announced—here’s what BIO’s saying about it. Plus, we recap BIO on the American Road in Illinois. (615 words, 3 minutes, 4 seconds) MFN threatens US ...

President Trump announced tariffs of 100% will apply to brand-name pharmaceuticals starting next week, unless a company is building a plant in the U.S. The announcement: “Starting October 1st, 2025, ...

Mark leads the Biotechnology team at Carpmaels & Ransford. Mark’s impressive Biotech-only practice focusses on the rapid and effective building of commercially valuable European patent portfolios for ...

America leads the world in biotechnology innovation. Yet the U.S. remains the only country where half of every dollar spent on medicine goes to middlemen and supply chain markups - rather than to ...

Pauline Newman was appointed by President Ronald W. Reagan in 1984. From 1969 to 1984, Judge Newman served as Director, Patent, Trademark and Licensing Department, FMC Corporation, and as house ...

Jonathan Barnett is director of the law school’s Media, Entertainment and Technology Law Program and the author of The Big Steal: Ideology, Interest, and the Undoing of Intellectual Property (Oxford ...

Emily Michiko Morris, an experienced teacher and scholar in specializing in patent law, particularly as it relates to biotechnology and university research, and is an expert on intellectual property ...